<DOC>
	<DOCNO>NCT00244166</DOCNO>
	<brief_summary>1. investigate whether steroid effective ankylose spondylitis 2. steroid effective describe quick work</brief_summary>
	<brief_title>Prednisolone Active Ankylosing Spondylitis ( AS )</brief_title>
	<detailed_description>Treatment inflammatory rheumatic condition glucocorticosteroids mainstay therapy . In rheumatic disease rheumatoid arthritis , systemic lupus erythematodes polymyalgia rheumatica glucocorticosteroids show prompt effect regard musculoskeletal symptom . Ankylosing spondylitis ( AS ) inflammatory rheumatic disease mainly affect spine . However peripheral joint , entheses eye also affect . The rheumatic symptom AS patient typically show good quick response treatment nonsteroidal antirheumatic drug ( NSAIDs ) . In contrast rheumatoid arthritis proof disease modify antirheumatic drug ( DMARDs ) work . Surprisingly common opinion , mainly base personal experience , glucocorticosteroids spondylarthropathies work . However reliable clinical study answer question . In literature last 20 year single report treatment AS highly dose methylprednisolone ( intravenous pulse therapy ) . The pretended lack effectiveness glucocorticosteroids surprise moreover NSAIDs effective well local intraarticular steroid injection include sacroiliac joint . In addition magnetic resonance image acute inflammatory lesion visualize especially subchondral edema bone marrow . Besides 70 % patient active AS show elevate inflammatory serum marker erythrocyte sedimentation rate ( ESR ) C-reactive protein ( CRP ) . Moreover could recently treatment AS patient monoclonal antibody TNFa ( Infliximab ) highly effective . TNFa important pro-inflammatory cytokine ( Brandt et al 2000 ) . For reason important urgent perform study treatment active AS glucocorticosteroids use evaluated measuring instrument .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1. ankylose spondylitis accord modify NY criterion 1984 2. age 18 70 year 3. insufficient response therapy NSAIDs 4 . BASDAI &gt; 4 5 . Previous therapy DMARDs ( sulfasalazine , methotrexate etc . ) steroids less equal 7,5mg allow , discontinue stable 4 week study start 6. write informed consent 1 . Pregnancy lactation 2. current severe infection last 3 month 3. suspect opportunistic infection past 2 month ( Herpes zoster , cytomegaly , Pneumocystis cariniiinfection ) , HIVinfection 4 . Malignancies 5. severe cardial , renal , hematological , endocrinological , pulmonal , gastrointestinal ( peptic ulcer ) neurological , hepatic ( viral toxic hepatitis ) concomitant disease , uncontrolled arterial hypertension remit thrombosis , embolism 6 . Diabetes mellitus increase blood glucose test 7. uncontrolled glaucoma 8. active immunization past 2 week plan next 8 week 9. pathologic laboratory test result : creatinine &gt; 200 Âµmol/l , liver enzymes &gt; 2,5 fold , AP &gt; 2,5 fold upper normal range 10. significant pathological change physical examination 11. clinical trial participation past 30 day screen 12. intake `` hard drug '' ( cocaine , heroin ) 13. therapy 7,5 mg prednisolone , intraarticular steroid past 4 week study start 14. current application retirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>treatment</keyword>
	<keyword>ankylose spondylitis</keyword>
	<keyword>prednisolone</keyword>
	<keyword>trial</keyword>
	<keyword>steroid</keyword>
</DOC>